live-attenuated hPIV3 vaccine (Ohio State University/Ohio State University Technology Commercialization and Knowledge Transfer)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namelive-attenuated hPIV3 vaccine (Ohio State University/Ohio State University Technology Commercialization and Knowledge Transfer)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Development/production technology > Live attenuated vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsParamyxoviridae Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesThe Ohio State University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesThe Ohio State University

Active IndicationsN/A

Inactive IndicationsParamyxoviridae Infections

Other Information

ATC CodeN/A